Recent findings from a comprehensive survey conducted by SK Life Science, Inc. highlight critical obstacles in the dialogue between epilepsy patients and healthcare providers. The study reveals that misunderstandings about symptom reporting, medication side effects, and treatment expectations continue to impede optimal care management. Patients reported feeling hesitant to fully disclose seizure experiences, fearing judgment or dismissal, which in turn leads to incomplete clinical assessments and suboptimal treatment plans.

The survey also pinpointed several key factors contributing to these communication breakdowns, including:

  • Time constraints during consultations limiting in-depth discussions.
  • Lack of standardized tools for symptom tracking shared between patients and providers.
  • Variability in patient health literacy affecting understanding of complex treatment regimens.
Barrier Percentage of Patients Reporting
Fear of stigma or judgment 42%
Inadequate symptom documentation 38%
Limited consultation time 45%
Confusion about medication effects 33%

Healthcare experts argue that these communication gaps not only delay diagnosis and intervention but also contribute to inaccurate seizure control assessments and increased risk of preventable complications. The findings underscore an urgent need for innovative communication strategies and digital health tools to bridge understanding and foster collaborative epilepsy care.